BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2819350)

  • 1. Rheumatoid arthritis and oral contraceptives in the Greek female population: a case-control study.
    Linos A; Kaklamanis E; Kontomerkos A; Vagiopoulos G; Tjonou A; Kaklamanis P
    Br J Rheumatol; 1989; 28 Suppl 1():37; discussion 42-5. PubMed ID: 2819350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis.
    Jorgensen C; Picot MC; Bologna C; Sany J
    Ann Rheum Dis; 1996 Feb; 55(2):94-8. PubMed ID: 8712873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal and reproductive influences and risk of melanoma in women.
    Smith MA; Fine JA; Barnhill RL; Berwick M
    Int J Epidemiol; 1998 Oct; 27(5):751-7. PubMed ID: 9839729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for pathologically confirmed benign breast disease.
    Parazzini F; La Vecchia C; Franceschi S; Decarli A; Gallus G; Regallo M; Liberati A; Tognoni G
    Am J Epidemiol; 1984 Jul; 120(1):115-22. PubMed ID: 6741913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors.
    Holman CD; Armstrong BK; Heenan PJ
    Br J Cancer; 1984 Nov; 50(5):673-80. PubMed ID: 6498065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for breast cancer in women undergoing mammography.
    Reuter KL; Baker SP; Krolikowski FJ
    AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women.
    Osterlind A; Tucker MA; Stone BJ; Jensen OM
    Int J Cancer; 1988 Dec; 42(6):821-4. PubMed ID: 3192324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron status markers, serum ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment.
    Milman N; Kirchhoff M; Jørgensen T
    Ann Hematol; 1992 Aug; 65(2):96-102. PubMed ID: 1511065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of oral contraception on the occurrence of rheumatoid arthritis in female sibs.
    Hazes JM; Silman AJ; Brand R; Spector TD; Walker DJ; Vandenbroucke JP
    Scand J Rheumatol; 1990; 19(4):306-10. PubMed ID: 2402603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study on the association between the use of oral contraception and cancer of the breast or cervix: preliminary findings of a French study].
    Le MG; Bachelot A; Doyen F; Kramar A
    Contracept Fertil Sex (Paris); 1985 Mar; 13(3):553-8. PubMed ID: 12280145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatoid arthritis, the contraceptive pill, and androgens.
    James WH
    Ann Rheum Dis; 1993 Jun; 52(6):470-4. PubMed ID: 8323402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.
    Chie WC; Li CY; Huang CS; Chang KJ; Yen ML; Lin RS
    Int J Cancer; 1998 Jul; 77(2):219-23. PubMed ID: 9650556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of oral contraceptive use to rheumatoid arthritis.
    Moskowitz MA; Jick SS; Burnside S; Wallis WJ; Dickson JF; Hunter JR; Jick H
    Epidemiology; 1990 Mar; 1(2):153-6. PubMed ID: 2073503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproductive and hormonal factors and breast cancer in a Northern Italian population.
    Talamini R; La Vecchia C; Franceschi S; Colombo F; Decarli A; Grattoni E; Grigoletto E; Tognoni G
    Int J Epidemiol; 1985 Mar; 14(1):70-4. PubMed ID: 3988443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives and risk of breast cancer.
    Paul C; Skegg DC; Spears GF
    Int J Cancer; 1990 Sep; 46(3):366-73. PubMed ID: 2394503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for epithelial ovarian tumours of borderline malignancy.
    Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
    Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
    McTiernan AM; Weiss NS; Daling JR
    Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When is it safe to switch from oral contraceptives to hormonal replacement therapy?
    Castracane VD; Gimpel T; Goldzieher JW
    Contraception; 1995 Dec; 52(6):371-6. PubMed ID: 8749601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives and rheumatoid arthritis: further evidence for a preventive effect.
    Vandenbroucke JP; Valkenburg HA; Boersma JW; Cats A; Festen JJ; Huber-Bruning O; Rasker JJ
    Lancet; 1982 Oct; 2(8303):839-42. PubMed ID: 6126710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.